• 제목/요약/키워드: Solid capsule

검색결과 35건 처리시간 0.021초

연질캡슐 피막물질로서 식물성 성분 원료와 젤라틴에 대한 품질특성 비교 (Comparative Characterization Study on Quality Attributes of Vegetable and Gelatin as Capsule Shell of Soft Capsule)

  • 김동욱;원권연
    • 약학회지
    • /
    • 제59권2호
    • /
    • pp.70-76
    • /
    • 2015
  • A Softgel is an oral dosage form for medicine similar to capsules and softgel dosage form offers several advantages over other oral dosage forms, such as delivering a liquid matrix designed to solubilize and improve the oral bioavailability of a poorly soluble compound as a unit dose solid dosage form, delivering low and ultra-low doses of a compound. This study aimed to qualify a proprietary vegetable soft capsule which contains modified starch and carrageenan as capsule shell components compare to the conventional gelatin softgel. Four kinds of samples were prepared with vegetable and gelatin capsule shell, respectively. Morphology of capsule shell, mechanical strength of capsule, and hygroscopic properties were studied for comparing the quality attributes of softgel. Short-term stability against heat and moisture was also investigated in this study. Vegetable capsule shell showed better mechanical strength, physical stability and disintegration time for temperature and humidity than those of conventional gelatin capsule shell with four different filling materials used frequently as soft capsule form. Conclusively, this vegetable capsule shell polymer system can replace easily gelatin-shell systems and additionally allows encapsulation of lipid fills at high temperatures that are semisolid or solid-like at room temperature.

Solid Dispersion of an HIV Protease Inhibitor

  • Park, Jae-Hyeon;Lee, Sung-Hack;Lee, Yong-Hee;Kim, Ae-Ri
    • Journal of Pharmaceutical Investigation
    • /
    • 제41권2호
    • /
    • pp.75-82
    • /
    • 2011
  • LB71350 is an HIV protease inhibitor with poor aqueous solubility and extensive first pass effect. The purpose of the present study was to test the feasibility of solid dosage form of LB71350 with improved bioavailability utilizing solid dispersion. Three different compositions with varying ratio of (LB71350: Gelucire 44/14: Tween 20) were studied. Capsule filling of these solid dispersion compositions was tested using a semi-automatic capsule filling system. Oral bioavailability in dog was tested. Chemical and physical stability at 4, 25 and $40^{\circ}C$ was monitored by HPLC assay, dissolution test, powder XRD and microscopy. The capsule filling system yielded uniform products of drug loading up to 10%. Oral bioavailability in dog was improved compared to the aqueous suspension of crystalline LB71350. Capsules were chemically stable for up to 6 months at $40^{\circ}C$. However, there were temperature and composition dependent physical changes. Decrease in dissolution rates after storage at $40^{\circ}C$ was due to the polymorphic change. In conclusion, manufacturing process, bioavailability, and physico-chemical stability have been considered to propose a solid dispersion capsule formulation for the HIV protease inhibitor with poor physico-chemical properties. A new less soluble crystalline form identified during the physical stability test warrants further study.

흰쥐에 경구 투여시 히드록시프로필-베타-시클로덱스트린과 니트렌디핀 고체분산에 의한 생체이용률 증가 (Enhancement of Nitrendipine Bioavailability in Rats by its Solid Dispersion with $Hydroxypropyl-{\beta}-Cyclodextrin$ after Oral Administration)

  • 용철순
    • Journal of Pharmaceutical Investigation
    • /
    • 제27권4호
    • /
    • pp.295-301
    • /
    • 1997
  • Nitrendipine, a slightly soluble calcium channel blocking agent forms a solid dispersion system with $hydroxypropyl-{\beta}-cyclodextrin$, which exhibits better dissolution characteristics than the uncomplexed drug. The dissolution rate of nitrendipine was markedly increased in solid dispersion system in pharmacopeial disintegration media at pH 1.2 and pH 6.8. Four different dosage forms of nitrendipine were administered to rats: (a) nitrendipine in the solution of PEG 400; (b) nitrendipine solid dispersion system with $hydroxypropyl-{\beta}-cyclodextrin$ in a molar ratio of 1:2 by solvent evaporation method and administered in capsule form; (c) physical mixture of nitrendipine with $hydroxypropyl-{\beta}-cyclodextrin$ in a molar ratio of 1:2 and administered in capsule form; (d) nitrendipine alone administered in capsule form. Relative bioavailability after the oral administration of various dosage forms to rats with a dose of 10 mg/kg equivalent to nitrendipine was compared with that of nitrendipine in the solution of PEG 400. The AUC of solid dispersion was significantly bigger than that of nitrendipine powder. $T_{max}$ of solid dispersion was significantly shorter and $C_{max}$ was higher than that of nitrendipine powder. These results indicate that the bioavailability of nitrendipine could be improved markedly by inclusion complexation. An interesting correlation also appears to exist between the in vitro dissolution data and the area under the plasma concentration-time curves.

  • PDF

구형용기내 고상의 하강운동을 고려한 융해과정의 해석 (An Analysis of Gravity-Assisted Melting of Subcooled Solid Filled Inside a Spherical Capsule)

  • 서정세;김찬중;노승탁
    • 대한기계학회논문집
    • /
    • 제17권10호
    • /
    • pp.2601-2610
    • /
    • 1993
  • A numerical study on the melting process inside an isothermal spherical capsule is made. It is assumed that the phase change medium of its solid phase is heavier than the liquid phase and therefore the unmelted solid core is continuously moving downward on account of gravity forces. Such a gravity-assisted melting is commonly characterized by the existence of a thin liquid film below the solid core. The present study is motivated to present a full-equation-based analysis of the influences of the initial subcooling and the natural convection on the fluid flow and heat transfer characteristics associated with the gravity-assisted melting. In the light of the solution strategy, the present study is substantially distinguished from the existing works in that the complete set of governing equations in both the melted and unmelted regions are resolved without subdivision of the solution domains. For example, the liquid film region and the upper melted region are treated here as one domain and thus obviating laborious efforts to couple them. Numerical results are obtained by varying the Rayleigh numbers and the degree of subcooling. For the range of parameters examined, the presence of subcooling was found to impede the melting rate. The dropping velocity of the unmelted solid core was observed to affect the natural convection in the liquid significantly. When compared with the available experimental data, much improved prediction was achieved.

캡슬에 고정화된 흡착제에의 Berberine의 흡착에 관한 수학적 모델 (Mathematical Model for Adsorption of Berberine on Encapsulated Adsorbent)

  • 최정우;조상원이원홍
    • KSBB Journal
    • /
    • 제10권4호
    • /
    • pp.358-369
    • /
    • 1995
  • A mathematical model using local thermodynamic equilibrium isotherms for adsorption in encapsulated adsorbent is proposed in order to optimize the design parameters in situ bioproduct separation process. The model accurately follows the experimental data on the adsorption of berberine, secondary metabolite produced in Thaictrum rugosum plant cell culture. The adsorption rate on encapsulated adsorbent is compared with that on alginate-entrapped adsorbent. The result shows that the higher loading capacity in encapsulated adsorbent is mainly due to the increase in the maximum solid phase concentration. Based on the adsorption rate and loading capacity, the encapsulated adsorbent would be more useful than the entrapped adsorbent when used in situ bioproduct separation process. Design parameters in situ bioproduct separation process, such as the size of the capsule, membrane thickness, the ratio of capsule volume to bulk volume, the ratio of single capsule volume to total capsule volume and the adsorbent content in the capsule, are evaluated by using the model. The ratio of single capsule volume to total capsule volume is the most effective parameter for adsorption of berberine on encapsulated adsorbent.

  • PDF

균열 유도 재령에 따른 결정성장형 자기치유 고상캡슐 활용 시멘트 모르타르의 균열 치유 특성 (The Crack Healing Properties of Cement Mortar Materials Using Crystal Growth Type Self-Healing Solid Capsules According to the Crack Induction Age)

  • 최연왕;남은준;김철규;오성록
    • 한국건설순환자원학회논문집
    • /
    • 제8권4호
    • /
    • pp.475-482
    • /
    • 2020
  • 본 연구에서는 결정성장형 자기치유 고상캡슐의 코어조성비에 따라 3수준의 고상캡슐을 제조하였으며, 결정성장형 자기치유 고상캡슐을 혼합하여 시멘트 모르타르를 제조하였다. 제조된 고상캡슐은 시멘트 질량의 3%와 혼합하여 시멘트 모르타르의 균열 유도 재령에 따른 치유 특성을 평가하였다. 결정성장형 자기치유 고상캡슐을 혼합한 시멘트 모르타르의 균열 유도 재령에 따른 균열치유 특성을 평가한 결과, 7일 재령 동안 반응하지 않은 수화물질이 남아있기 때문에 고상캡슐과 혼합된 시멘트 모르타르의 자기치유 성능은 28일 재령 대비 7일 재령이 증가한 것으로 나타났다.

고상캡슐을 활용한 자기치유 표면보호재의 품질 및 장기재령 치유특성 (Quality and Long-tern Aged Healing Properties of Self-healing Surface Protection Materials Using Solid Capsules)

  • 오성록;남은준;강신택;최연왕
    • 한국건설순환자원학회논문집
    • /
    • 제9권3호
    • /
    • pp.397-404
    • /
    • 2021
  • 본 연구에서는 고상캡슐을 활용한 자기치유 표면보호재를 보수재료로 활용하기 위한 일환의 연구로써 고상캡슐이 표면보호재의 품질에 미치는 영향 및 장기재령의 치유 특성을 검토하였다. 고상캡슐 혼합에 따른 자기치유 표면보호재의 유변학적 특성 평가결과, 소성점도 및 항복응력, 테이블 플로우는 감소하는 경향이 나타났으며, 압축강도의 경우 고상캡슐 1%당 1 MPa이 비례적으로 감소하였다. 장기재령 치유특성을 평가한 결과, 재령 91일이 경과된 경우에도 고상캡슐이 보존되어 10% 혼합한 경우 치유재령 28일에 90% 수준의 치유율이 나타났으며, 치유재령 91일 경과후에는 고상캡슐 5%의 경우에도 90% 수준의 치유율이 나타났다.

결정성장형 무기재료 활용 고상 캡슐을 혼합한 자기치유 모르타르의 품질 및 균열 치유 특성에 관한 실험적 연구 (An Experimental Study on the Quality and Crack Healing Properties of Self-Healing Mortar Containing Solid Capsules using Crystal Growth Type Inorganic Materials)

  • 오성록;김철규;남은준;최연왕
    • 한국건설순환자원학회논문집
    • /
    • 제8권1호
    • /
    • pp.120-128
    • /
    • 2020
  • 본 연구에서는 모르타르와 직접 혼합 가능한 결정성장형 무기재료 활용 고상 캡슐을 제조하였으며, 결정성장형 무기재료 조성비에 따라 3수준의 고상 캡슐을 제조하였다. 제조된 고상 캡슐은 시멘트 질량에 3% 혼합하여 모르타르의 품질 및 균열 치유 특성을 평가하였다. 고상 캡슐을 혼합한 모르타르의 테이블 플로우 및 공기량 평가결과 고상 캡슐의 혼합에 관계없이 테이블 플로우 및 공기량에 미치는 영향은 없는 것으로 나타났다. 고상 캡슐을 혼합한 모르타르의 water flow test 및 crack closing test에 따른 균열 치유특성 평가결과 초기 투수량이 감소하는 결과가 나타났으며, 시간 경과에 따라 반응생성물 발생하여 균열이 치유되는 것을 확인할 수 있었다.

결정성장형 무기재료 조성비에 따른 고상 캡슐의 자기치유 성능에 관한 실험적 연구 (An Experimental Study on the Self-Healing Performance of Solid Capsules According to the Composition Ratio of Crystal Growth Type Inorganic Materials)

  • 남은준;오성록;김철규;최연왕
    • 한국구조물진단유지관리공학회 논문집
    • /
    • 제25권2호
    • /
    • pp.16-22
    • /
    • 2021
  • 본 논문에서는 수화반응이 가능한 결정성장형 무기재료를 사용하여 고상 캡슐을 제조하였다. 고상 캡슐을 시멘트 질량 기준으로 8:2, 7:3, 및 6:4의 조성비에 따라 3, 5 및 10% 혼합하여 자기치유 모르타르 배합을 진행 하였으며, 정수위투수시험을 통해 내구적 치유 특성을 평가하였다. 정수위투수시험 실험결과, 고상 캡슐의 조성비 7:3으로 제조된 고상 캡슐을 혼합함에 따라 자연 치유성능을 최적으로 향상시키는 효과가 나타났다. 0.3 mm 이하 균열폭의 경우 약 90% 이상 자기치유 성능을 확보할 수 있을 것으로 판단된다. 이러한 결과, 고상 캡슐의 자기치유 성능은 정수위투수시험을 통하여 내구적 치유 특성에 영향이 있는 것으로 판단되며, 고상 캡슐의 혼합에 따라서 자기치유 성능을 향상시키는 경향이 있다고 판단된다.

캡슐 하단부 구조변경에 따른 압력강하 및 진동특성 (Pressure Drop and Vibration Characteristics of the Capsule with the Modification of Bottom Structures)

  • 최명환;주기남;조만순;김봉구
    • 한국소음진동공학회논문집
    • /
    • 제15권12호
    • /
    • pp.1370-1377
    • /
    • 2005
  • The bottom structure of an instrumented capsule is a part which is joined at the receptacle of the flow tube in the reactor in-core. A geometrical change of the bottom structure has an effect on the pressure drop and the vibration of the capsule. The out-pile test to evaluate the structural integrity of the material capsule called 04M-17U was performed by using a single channel and a half core test loop. From the pressure drop test, the optimized diameter of the cone shape's bottom structure which satisfies HANARO's flow requirement (19.6 kg/s) is 71 mm. The maximum displacement of the capsule measured at the half core test loop is lower than 1.0 mm. From the analysis results, it is found that the test hole will not be interfered with near the flow tubes because its displacement due to the cooling water is very small at 0.072 mm. The fundamental frequency of the capsule under water is 9.64 Hz. It is expected that the resonance between the capsule and the fluid flow due to the cooling water in HANARO's in-core will not occur. Also, the new bottom structure of a solid cone shape with 71 mm in diameter will be applicable to the material and special capsules in the future.